AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 22451347
Drug: Echinacea angustifolia
RxNorm normalized name: Echinacea Angustifolia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Echinacea angustifolia extract (20 mg, 1 tablet per day)
Trial: 22451347
Drug: Echinacea angustifolia
RxNorm normalized name: Echinacea Angustifolia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Echinacea angustifolia extract (1000 and 3000 mg/kg) in rats
Trial: 22451347
Drug: Echinacea angustifolia
RxNorm normalized name: Echinacea Angustifolia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Echinacea angustifolia extract (various doses) in rats
Trial: 17081623
Drug: Interferon-beta treatment
RxNorm normalized name: interferon-beta
DrugBank: Human interferon beta (DB14999)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon-beta treatment
Trial: 9489643
Drug: PBPC infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: PBPC infusion over 1 day
Trial: 9489643
Drug: PBPC infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: PBPC infusion over 2 days
Trial: 9489643
Drug: PBPC infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: PBPC infusion over 3 days
Trial: 9489643
Drug: PBPC infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: PBPC infusion as a single infusion
Trial: 9489643
Drug: PBPC infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: PBPC infusion over 1, 2 or 3 days
Trial: 8165854
Drug: Four-dose schedule
RxNorm normalized name: Four-Way
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Four-dose schedule (40 micrograms each at 0, 1, 2, and 6 months)
Trial: 8165854
Drug: Three-dose schedule
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three-dose schedule (40 micrograms each at 0, 1, and 6 months)
Trial: 8165854
Drug: Three-dose schedule
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three-dose schedule (half the amount of vaccine) in healthy controls
Trial: 8165854
Drug: Four-dose schedule
RxNorm normalized name: Four-Way
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Four-dose schedule
Trial: 8165854
Drug: Three-dose schedule
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three-dose schedule
Trial: 8165854
Drug: Three-dose schedule
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three-dose schedule in healthy controls
Trial: 8165854
Drug: Four-dose and
RxNorm normalized name: Four-Way
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Four-dose and three-dose schedules
Trial: 3073355
Drug: TISACID (Al-Mg-hydroxy-carbonate)
RxNorm normalized name: alpha hydroxy acids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TISACID (Al-Mg-hydroxy-carbonate)
Trial: 3073355
Drug: TISACID (Al-Mg-hydroxy-carbonate)
RxNorm normalized name: alpha hydroxy acids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TISACID (Al-Mg-hydroxy-carbonate) with cimetidine
Trial: 29637322
Drug: Early education
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early education treatment group
Trial: 29637322
Drug: Intensive early
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive early educational treatment
Trial: 22162542
Drug: Telaprevir 750
RxNorm normalized name: Telaprevir
DrugBank: Telaprevir (DB05521)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Telaprevir 750 mg every 8 hours from day 8 through day 23
Trial: 12222545
Drug: 30-gauge, 5/16-inch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30-gauge, 5/16-inch insulin syringe
Trial: 10520785
Drug: Adjunctive percutaneous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjunctive percutaneous transluminal coronary angioplasty (PTCA) after DCA
Trial: 10520785
Drug: Adjunctive PTCA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjunctive PTCA
Trial: 7486603
Drug: 30-mg dose
RxNorm normalized name: pasireotide 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30-mg dose of nimodipine
Trial: 7486603
Drug: 60-mg dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60-mg dose of nimodipine
Trial: 2138490
Drug: Mivacurium chloride
RxNorm normalized name: Mivacurium Chloride
DrugBank: Mivacurium (DB01226)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mivacurium chloride (0.15 mg kg‐1) during nitrous oxide-fentanyl-thiopentone anaesthesia (BAL group)
Trial: 2138490
Drug: Mivacurium chloride
RxNorm normalized name: Mivacurium Chloride
DrugBank: Mivacurium (DB01226)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mivacurium chloride (0.15 mg kg‐1) during nitrous oxide-halothane anaesthesia (HAL group)
Trial: 2138490
Drug: Mivacurium chloride
RxNorm normalized name: Mivacurium Chloride
DrugBank: Mivacurium (DB01226)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mivacurium chloride (various doses)
Trial: 7328681
Drug: Communication therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Communication therapy
Trial: 30302786
Drug: Risdiplam (0.6-18.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risdiplam (0.6-18.0 mg, n=18)
Trial: 28675594
Drug: Single-dose letermovir
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose letermovir (120, 240, 480, 720, and 960 mg)
Trial: 28675594
Drug: Multiple-dose letermovir
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple-dose letermovir (240 mg, once-daily)
Trial: 24950277
Drug: Delayed varicosity
RxNorm normalized name: DIMETHICONE 30 mg in 1 mL TOPICAL CREAM [AnYi Beauty Varicose Veins Cream]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed varicosity treatment
Trial: 24495792
Drug: Telmisartan plus
RxNorm normalized name: Telmisartan
DrugBank: Telmisartan (DB00966)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Telmisartan plus rosuvastatin (combination group)
Trial: 22814578
Drug: Pyridoxine (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pyridoxine (50 mg po three times daily)
Trial: 16371925
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose (two capsules of Oxy-Q containing 480 mg of curcumin and 20 mg of quercetin)
Trial: 16371925
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose (one capsule of Oxy-Q containing 480 mg of curcumin and 20 mg of quercetin)
Trial: 16371925
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose (one capsule of Oxy-Q)
Trial: 16371925
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose (two capsules of Oxy-Q)
Trial: 16371925
Drug: Control (placebo)
RxNorm normalized name: Afeditab CR
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control (placebo) and Low dose (one capsule of Oxy-Q)
Trial: 12669769
Drug: Fixed-dose combination
RxNorm normalized name: Progestogens and estrogens, fixed combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed-dose combination of rifampicin, isoniazid, and pyrazinamid (Trifazid)
Trial: 12669769
Drug: Separate administration
RxNorm normalized name: Atractylis separate root
DrugBank: Atractylodes lancea root (DB14693)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Separate administration of rifampicin, isoniazid, and pyrazinamid
Trial: 7917561
Drug: Sclerotherapy plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sclerotherapy plus nadolol (mean final dose: 82 +/- 31 mg/d)
Trial: 380184
Drug: iopronic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: iopronic acid (4.5 g Oravue, Squibb)
Trial: 380184
Drug: iopanoic acid
RxNorm normalized name: Iopanoic Acid
DrugBank: Iopanoic acid (DB08946)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: iopanoic acid (3 g Telepaque, Winthrop)
Trial: 30782258
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg moclobemide tablets (Jelfa)
Trial: 30782258
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg Aurorix tablets (Hoffmann la Roche)
Trial: 29109107
Drug: Web site
RxNorm normalized name: miconazole
DrugBank: Miconazole (DB01110)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Web site with vaccine information and interactive social media components (VSM)
Trial: 29109107
Drug: Web site
RxNorm normalized name: miconazole
DrugBank: Miconazole (DB01110)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Web site with vaccine information (VI)
Trial: 19426108
Drug: Thrombin solution
RxNorm normalized name: thrombin
DrugBank: Thrombin (DB11300)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrombin solution (100 unit/ml) irrigation
Trial: 19426108
Drug: Saline solution
RxNorm normalized name: Unisol 4 Saline Solution
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline solution irrigation with anti-platelet medication
Trial: 19426108
Drug: Thrombin solution
RxNorm normalized name: thrombin
DrugBank: Thrombin (DB11300)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrombin solution irrigation with anti-platelet medication
Trial: 9719164
Drug: 20% albumin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20% albumin infusion 100 ml three times per week for 2 weeks
Trial: 9719164
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no albumin infusion)
Trial: 9719164
Drug: Four weeks
RxNorm normalized name: Four-Way
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Four weeks after withdrawal of albumin infusion
Trial: 2673623
Drug: Moclobemide 200
RxNorm normalized name: moclobemide
DrugBank: Moclobemide (DB01171)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moclobemide 200 mg t.i.d.
Trial: 2673623
Drug: Tranylcypromine 10
RxNorm normalized name: tranylcypromine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tranylcypromine 10 mg b.i.d.
Trial: 1273208
Drug: Haloperidol 0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haloperidol 0.25 mg
Trial: 23138261
Drug: Haloperidol 0.5
RxNorm normalized name: haloperidol 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haloperidol 0.5 mg
Trial: 29020329
Drug: Vitamin D3
RxNorm normalized name: Vitamin D3
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D3 (VITD3) 50000 IU monthly plus daily multivitamin containing VITD3 400 IU and calcium 162 mg
Trial: 29020329
Drug: Placebo plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo plus daily multivitamin containing VITD3 400 IU and calcium 162 mg
Trial: 20513595
Drug: Use of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Use of heparin + a glycoprotein IIb/IIIa inhibitor
Trial: 16035144
Drug: Methylphenidate (MPH)
DrugBank: Methylphenidate (DB00422)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methylphenidate (MPH) 5 mg
Trial: 7822629
Drug: Methylphenidate (MPH)
DrugBank: Methylphenidate (DB00422)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methylphenidate (MPH) 10 mg
Trial: 16035144
Drug: Methylphenidate (MPH)
DrugBank: Methylphenidate (DB00422)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methylphenidate (MPH) 15 mg
Trial: 9527752
Drug: Clorazepate-dipotassium (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clorazepate-dipotassium (20 mg)
Trial: 7614911
Drug: Aspartame (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspartame (50 mg/kg)
Trial: 775990
Drug: Loridine-Keflex prophylaxis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loridine-Keflex prophylaxis (antibiotics)
Trial: 29275697
Drug: General functioning
FDA approved: no
EMA approved: no
PMDA approved: no
Description: General functioning improvement treatments
Trial: 24549371
Drug: JNJ‐39758979 (H(4)R
FDA approved: no
EMA approved: no
PMDA approved: no
Description: JNJ‐39758979 (H(4)R antagonist)
Trial: 23032552
Drug: Mexiletine 200
RxNorm normalized name: mexiletine 200 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mexiletine 200 mg orally 3 times daily for 4 weeks
Trial: 9389860
Drug: Rocuronium 1
RxNorm normalized name: rocuronium 10 mg/mL intravenous solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rocuronium 1 ml (10 mg)
Trial: 9389860
Drug: 0.9% NaCl
RxNorm normalized name: Trace Metals Additive in 0.9% NaCl
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.9% NaCl 1 ml (placebo)
Trial: 9389860
Drug: Rocuronium (second
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rocuronium (second injection)
Trial: 7948796
Drug: Amrinone (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amrinone (2 mg/kg bolus during CPB)
Trial: 31198594
Drug: Oral misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral misoprostol (600 μg)
Trial: 24564041
Drug: Pulsed electromagnetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulsed electromagnetic field (PEMF) therapy plus medications (analgesics, nonsteroidal anti-inflammatory - diclofenac sodium)
Trial: 24564041
Drug: Standard medications
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard medications (analgesics, nonsteroidal anti-inflammatory - diclofenac sodium)
Trial: 22247928
Drug: Topical 1%
RxNorm normalized name: fluoride topical 1% topical gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical 1% lidocaine cream
Trial: 16476120
Drug: Supportive therapies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supportive therapies only (Control)
Trial: 12897047
Drug: Zinc supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc supplementation (30 mg/day of Zn as Zn gluconate)
Trial: 9433655
Drug: grepafloxacin 600
RxNorm normalized name: grepafloxacin 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: grepafloxacin 600 mg once daily for 10 days with theophylline
Trial: 9433655
Drug: grepafloxacin 600
RxNorm normalized name: grepafloxacin 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: grepafloxacin 600 mg once daily for 14 days with warfarin
Trial: 8431336
Drug: Free clear
RxNorm normalized name: Guaifenesin 100 mg in 5 mL / Dextromethorphan Hydrobromide 10 mg in 5 mL ORAL SOLUTION [Robafen DM Cough Sugar Free Clear]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Free clear fluids intake until premedication (mean 388 ml in 6 h before surgery)
Trial: 24619763
Drug: Alendronate (ALN)
RxNorm normalized name: alendronate
DrugBank: Alendronic acid (DB00630)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alendronate (ALN) 70 mg/week (n=41)
Trial: 24619763
Drug: Raloxifene (RAL)
DrugBank: Raloxifene (DB00481)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Raloxifene (RAL) 60 mg/d (n=37)
Trial: 24619763
Drug: No additional
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No additional medication (n=47)
Trial: 22450724
Drug: Remifentanil (0.02
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remifentanil (0.02 mg/mL)
Trial: 22450724
Drug: Alfentanil 1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alfentanil 1 (0.04 mg/mL)
Trial: 22450724
Drug: Alfentanil 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alfentanil 2 (0.08 mg/mL)
Trial: 18208877
Drug: Methotrexate (MTX)
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Methotrexate (MTX) 20 mg PO
Trial: 18208877
Drug: IV methylprednisolone
RxNorm normalized name: Methylprednisolone
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: IV methylprednisolone (IVMP) 1,000 mg/day for three days every other month
Trial: 18208877
Drug: Intramuscular interferon
RxNorm normalized name: Interferon Gamma
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular interferon beta-1a (IM IFNbeta-1a) 30 mcg IM weekly
Trial: 16436547
Drug: Atomoxetine (maximum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atomoxetine (maximum dose 1.8 mg/kg/day; n = 102)
Trial: 9429680
Drug: Structured communication
RxNorm normalized name: LIPID,STRUCTURED (FROM SUNFLOWER OIL)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Structured communication program (discussion with a nurse, informational pamphlet, daily telephone call)
Trial: 2757885
Drug: Inhaled NAAGA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled NAAGA (60 mg thrice daily for 1 week)
Trial: 180199
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg of adenine arabinoside/kg per day
Trial: 180199
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg of adenine arabinoside/kg per day
Trial: 180199
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg of adenine arabinoside/kg per day
Trial: 180199
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg of adenine arabinoside/kg per day
Trial: 31697972
Drug: MSDC-0602K 62.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MSDC-0602K 62.5 mg
Trial: 31697972
Drug: MSDC-0602K 125
RxNorm normalized name: MSDC-0160
DrugBank: Mitoglitazone (DB11721)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MSDC-0602K 125 mg
Trial: 31697972
Drug: MSDC-0602K 250
RxNorm normalized name: MSDC-0160
DrugBank: Mitoglitazone (DB11721)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MSDC-0602K 250 mg
Trial: 31697972
Drug: MSDC-0602K (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MSDC-0602K (all doses)
Trial: 31783602
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D supplementation (100,000 IU loading dose of cholecalciferol followed by 4000 IU daily for 16 weeks)
Trial: 26228576
Drug: New chewable
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New chewable benazepril hydrochloride tablet (0.5 mg/kg p.o.)
Trial: 26228576
Drug: Branded formulation
RxNorm normalized name: Eagle Brand Medicated Oil
DrugBank: Eucalyptus oil (DB11114)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Branded formulation (Fortekor®)
Trial: 22065305
Drug: 3 mg
RxNorm normalized name: boron 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg of norgestomet implant for 9 days with 500 IU PMSG at implant removal
Trial: 22065305
Drug: 3 mg
RxNorm normalized name: boron 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg of norgestomet implant for 9 days without PMSG
Trial: 22065305
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group without hormonal treatment
Trial: 19713152
Drug: AVI-4658 (0.09
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AVI-4658 (0.09 mg in 900 microL saline)
Trial: 19713152
Drug: AVI-4658 (0.9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AVI-4658 (0.9 mg in 900 microL saline)
Trial: 15231012
Drug: Alendronate 10
RxNorm normalized name: ALENDRONATE 10MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alendronate 10 mg/day and 5 mg/day
Trial: 15231012
Drug: Alendronate (combined
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alendronate (combined 5 mg and 10 mg groups)
Trial: 15028823
Drug: Discontinuation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Discontinuation of alendronate
Trial: 9836078
Drug: Bone metabolism
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bone metabolism imbalance in IBD patients
Trial: 1098888
Drug: Fludrocortisone (0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fludrocortisone (0.3 mg for seven days)
Trial: 21606192
Drug: DHEA 50
RxNorm normalized name: Natrol Mood & Stress DHEA 50mg Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHEA 50 mg for 6 months
Trial: 20050483
Drug: Traditional oral
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Traditional oral handover
Trial: 16948972
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C (500 mg twice a day) and Vitamin E (400 IU per day)
Trial: 16948972
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no vitamin therapy)
Trial: 9435196
Drug: Lisofylline (LSF)
RxNorm normalized name: Lisofylline
DrugBank: Lisofylline (DB12406)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lisofylline (LSF) at doses of 1, 2, or 3 mg/kg every 24 hr for 3 days by 10 min intravenous infusion
Trial: 8010459
Drug: Buprenorphine 0.4
RxNorm normalized name: buprenorphine 0.4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buprenorphine 0.4 mg and indomethacin 50 mg (Group A)
Trial: 8010459
Drug: Buprenorphine 0.4
RxNorm normalized name: buprenorphine 0.4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buprenorphine 0.4 mg (Group B)
Trial: 8010459
Drug: Indomethacin 50
RxNorm normalized name: indomethacin 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin 50 mg (Group C)
Trial: 8010459
Drug: No drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No drug (Group D)
Trial: 799980
Drug: Isoetharine ('Numotac')
RxNorm normalized name: Isoetharine
DrugBank: Isoetharine (DB00221)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isoetharine ('Numotac') 10 mg
Trial: 799980
Drug: Isoetharine ('Numotac')
RxNorm normalized name: Isoetharine
DrugBank: Isoetharine (DB00221)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isoetharine ('Numotac') 20 mg